Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications.
Sylwia WójcikKatarzyna Mocny-PachońskaSophie Bisch-WójcikAgnieszka BaliczTadeusz MorawiecPublished in: International journal of environmental research and public health (2022)
The development of medicine is based not only on the introduction of new methods of treatment, but also on the use of increasingly effective drugs, including antithrombotic drugs. Drugs that inhibit the activity of platelets (antiplatelet and anti-aggregating drugs) and pharmaceuticals that inhibit the activity of plasma coagulation factors (anticoagulants) are used in antithrombotic therapy. In our daily practice we encounter patients who take chronic antiplatelet or anticoagulant drugs. However, more and more often we are dealing with patients who are treated with two antiplatelet drugs, an antiplatelet and an anticoagulant or even undergoing triple antithrombotic therapy. When preparing the patient for invasive craniofacial procedures, it should be assessed whether the temporary discontinuation of antithrombotic treatment due to the fear of excessive perioperative bleeding is justified and will not result in life-threatening thromboembolic complications. The authors discuss in detail the medications used in modern antithrombotic treatment and present a perioperative management procedure with a patient who takes l4 z of these medications chronically.
Keyphrases
- atrial fibrillation
- end stage renal disease
- newly diagnosed
- ejection fraction
- cardiac surgery
- patients undergoing
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- minimally invasive
- primary care
- healthcare
- stem cells
- venous thromboembolism
- risk factors
- patient reported outcomes
- mesenchymal stem cells
- patient reported
- weight loss
- smoking cessation
- prefrontal cortex